ASPEN PHARMACARE HOLDINGS LIMITED (Incorporated in the Republic of South Africa) Registration number: 1985/002935/06 Share code: APN ISIN: ZAE000066692 (“Aspen” or “the Company”) REMINDER OF THE RELEASE OF ASPEN’S INTERIM RESULTS FOR THE SIX MONTHS ENDED 31st DECEMBER 2023 AND A LIVE PRESENTATION THEREOF Shareholders are advised that Aspen intends releasing its results for the six months ended 31st December 2023 on Monday, 4th March 2024 on SENS at 13:00pm (SAST, GMT+2) with a presentation to members of the investment community in-person at the Bank of America Sun City conference and via webcast on Tuesday, 5th March 2024 at 08:30am (SAST, GMT+2). All interested stakeholders are invited to watch the live webcast which can be accessed using the following link: https://www.corpcam.com/Aspen05032024. In-person attendees are requested to RSVP using the following link: https://aspenpharmaforms.com/view.php?id=31392. The slides accompanying the presentation will be available on the Aspen website (www.aspenpharma.com) from the home page shortly before the commencement of the presentation on Tuesday, 5th March 2024. A playback of the webcast will be made available on our website approximately 2 hours after the presentation. Durban 27 February 2024 Sponsor: Investec Bank Limited